x
ServiziMenu principaleHome
You are here: Home > About us > ESO core faculty > Principles of Clinical Trials and Systemic Therapy
Print

Principles of Clinical Trials and Systemic Therapy

Medical Oncology

Matti S. Aapro, Clinique de Genolier, Oncology Dpt., Genolier, Switzerland
Stefan Aebi, Lucerne Cantonal Hospital, Dept. of Medical Oncology, Lucerne, Switzerland
Jonas Bergh, Karolinska Institute & University Hospital, Department of Oncology-Pathology, Stockholm, Sweden
Jean-Yves Blay, University Claude Bernard Lyon I, Centre Léon Bérard, Dept. of Medicine, Lyon, France
David A. Cameron, The University of Edinburgh, Edinburgh Cancer Research Centre, Edinburgh, United Kingdom
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, Portugal
Franco Cavalli, Hospital San Giovanni, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Thomas Cerny, Cantonal Hospital, Dept. of Oncology/Haematology, St. Gallen, Switzerland
Pier Franco Conte, Veneto Oncological Institute, Medical Oncology Dpt., Padoa, Italy
Giuseppe Curigliano, European Institute of Oncology, Department of Medicine, Division of Experimental Therapeutics, Milano, Italy
Johann S. de Bono, The Royal Marsden Hospital, Institue of Cancer Research, Sutton, United Kingdom
Francesco De Lorenzo, ECPC, Roma, Italy
Massimo Di Maio, University of Turin, A.O. Ordine Mauriziano, Director, SCDU Oncology, Turin, Italy
Don Dizon, Massachusetts General Hospital Cancer Center/Harvard Medical School, Oncology Dpt., Boston, USA
Elizabeth Eisenhauer, Queen's University, Dept. of Oncology, Kingston, Ontario, Canada
Alexandru Eniu, Cancer Institute Ion Chiricuta, Dept. of  Breast Cancer    Cluj-Napoca, Romania
Enriqueta Felip, Vall d'Hebron University Hospital, Dept. of Oncology, Barcelona, Spain
Martin F. Fey, Universität Bern, Klinik Für Medizinische Onkologie, Berne, Switzerland
Aleksandra Filipovic, London, United Kingdom
Rabab Gaafar, National Cancer Institute, Medical Oncology Dpt., Cairo, Egypt
Alessandra Gennari, Galliera Hospital, Department of Medical Oncology, Genoa, Italy
Joseph Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Dept. of Medical Oncology, Paris, France
Ian Magrath, INCTR Int. Network for Cancer Treatment and Research, President Office, Brussels, Belgium
Nicolas Mottet, University Jean Monnet, Dept. of Urology, Saint Etienne, France
George Pentheroudakis, Ioannina, Greece
Cornelis J.A. Punt, Academic Medical Center, University of Amsterdam, Dept. of Medical Oncology, Amsterdam, The Netherlands
Christian Rolfo, University Hospital Antwerp, Head of Phase I Early Clinical Trial Unit, Dir. Cllinical Trial Man Program, Edegem, Belgium
Ramon Salazar, Catalan Institute of Oncology, Medical oncology dpt., Barcelona, Spain
Litière Saskia, EORTC HQ, Statistic Dpt., Brussels, Belgium
Hans-Joachim Schmoll, Martin Luther University, Dept. of Internal Oncology , Halle, Germany
Dirk Schrijvers, Network Hospital of Antwerpen and Middelheim, Dept. of Medical Oncology, Antwerp, Belgium
Bostjan Seruga, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, Slovenia
Cristiana Sessa, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, Switzerland
Dan Stark, St James's Hospital, Dept. of Oncology, Leeds, United Kingdom
Anastasios Stathis, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, Switzerland
Stephan Stilgenbauer, University of Ulm, Dept. of Internal Medicine 3, Haematology and Oncology, Ulm, Germany
Josep Tabernero, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Medical Oncology Dpt., Barcelona, Spain
Ian Tannock
, Princess Margaret Cancer Center - University of Toronto, Dept. of Oncology and Hematology, Toronto, Canada
Jaap Verweij, Erasmus University Medical Centre, Dept. of Oncology, Rotterdam, The Netherlands

Pathology

Manuela A. Hoechstetter, Klinikum Schwabing , Klinik für Hämatologie, Onkologie, Immunologie, Palliativmed, Munich, Germany

Public Health

Paolo Bruzzi, National Institute for the Cancer Research, Clinical Epidemiology Dpt., Genoa, Italy
Mike Clarke, Queen's University Belfast, Centre for Public Health, Belfast, United Kingdom
Francesco Pignatti, European Medicines Agency, Scientific & Regulatory Management, Department Oncology, Haematology & Diagnostics, London, United Kingdom

Surgical Oncology

Rajendra Badwe, Tata Memorial Hospital, Dept. of Surgical Oncology, Mumbai, India
Alexander van Akkooi, Netherlands Cancer Institute, Dept. of Surgical Oncology, Amsterdam, The Netherlands
Cornelis van de Velde, Leiden University Medical Center, Dept. of Surgery, Leiden, The Netherlands

Other
Luca Chiapperino,  European School of Molecular Medicine (SEMM), Dept. of Health Sciences, Milano, Italy, Philosophy
Romano Danesi, University of Pisa, Dept. Of Clinical and sperimental medicine, Pisa, Italy, Clinical pharmacology

Follow us